Clinical trial
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic…
NCT00263601 · Allergopharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00263601 |
|---|---|
| Title | Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis |
| Official title | A Multicentre, Placebo Controlled, Double-Blind Study for Evaluation of Safety and Efficacy of Preseasonal Specific Immunotherapy With an Allergoid Preparation of an Extract of a 6 Grass Pollen Mixture in Patients With Clinically Relevant Grass Pollen Sensitivity |
| Lead sponsor | Allergopharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Grass Pollen Allergy |
| Intervention type | Biological, Other |
| Interventions | Allergovit 6-grasses, Placebo |
| Enrollment | 154 |
| Start date | Nov 1, 2001 |
| Primary completion | May 1, 2004 |
| Completion | Aug 1, 2010 |
| First posted | Dec 9, 2005 |
| Last update posted | Jun 5, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: